Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Illumina Names Klausner as SVP, CMO

Premium

Illumina said this week that it has appointed Richard Klausner as senior vice president and chief medical officer.

Prior to joining Illumina, Klausner was managing partner of venture capital firm The Column Group. He has also served as executive director for global health at the Bill and Melinda Gates Foundation, and as the eleventh director of the National Cancer Institute between 1995 and 2001. Klausner has also been chief of cell biology and metabolism at the National Institute of Child Health and Human Development; past president of the American Society of Clinical Investigation; and chairman of the National Science Education Standards Projects of the National Academy of Sciences. He holds an MD from Duke University.


Gregory Lucier has been appointed to the board of directors at RainTree Oncology and elected chairman of the board at Sanford-Burnham Medical Research Institute.

Lucier is CEO and chairman of Life Technologies. He also serves on the boards of CareFusion, Synthetic Genomics, and Rady Children's Hospital. He holds a BS in engineering from Pennsylvania State University and an MBA from Harvard Business School.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.